Researchers in Molecular & Cellular Proteomics have identified key proteins involved in schistosomiasis, a tropical disease affecting up to 200 million people. The study also reveals the structural proteome of a lethal shrimp viral disease and unique proteins allowing algae to thrive in salty environments.
Researchers have identified a protein on the surface of platelets that plays a key role in cancer-induced platelet aggregation, allowing cancer cells to evade the immune system and spread throughout the body. By blocking the interaction between podoplanin and CLEC-2, it may be possible to prevent tumor metastasis.
Scientists discovered that genetic variations do not negatively affect the efficacy of fluvastatin in renal transplant patients. Additionally, researchers created synthetic lipids called pseudoceramides to treat skin diseases and found them to significantly increase protein production when skin cells differentiate.
Researchers have identified new proteins in amniotic fluid that could improve pregnancy marker development. Additionally, a study on the Wlds gene has provided insights into preventing neuronal communication deterioration in Alzheimer's disease. A comprehensive analysis of proteins in human Jurkat T cells has also been conducted.
Recent mouse breeds designed to mimic Alzheimer's disease symptoms may not accurately reflect the human condition, according to a new study. The researchers suggest using alternative mouse breeds with only APP mutations to improve the accuracy of drug testing.
Researchers discovered a genetic variation that causes overexpression of Neuregulin 1 type 4 in the human brain, which may contribute to schizophrenia. This study provides new insight into the disease's underlying biology and could lead to improved therapies.
Eight scientists and one politician have been recognized by ASBMB for their groundbreaking work, advancing the field of biochemistry and molecular biology. The awards will be presented at Experimental Biology 2008 meeting in San Diego.
Researchers have discovered a new enzyme, UBE1L2, that plays a crucial role in protein degradation and is highly expressed in the testis. This finding challenges the long-held assumption that protein degradation is initiated by only one enzyme, suggesting a more complex process involving two proteins.
Scientists have discovered that adding more fish oil to the diet can decrease the formation of prostanoids, which contribute to inflammation in various tissues. This finding may lead to the development of new anti-inflammatory drugs with fewer side effects than current options.
A study by Richard E. Morton and Lahoucine Izem found that the protein cholesteryl ester transfer protein (CETP) plays a crucial role in fat cell storage and regulation, potentially leading to improved understanding of obesity and diabetes.
The studies identified new proteins involved in coronary heart disease, clusterin responsible for colorectal cancer progression, and potential biomarkers for esophageal cancer detection. These findings may lead to improved diagnosis and therapies for these diseases.
Researchers have made promising breakthroughs in understanding how antibodies can reduce the main hallmarks of Alzheimer's disease, including memory loss and ability to learn. The study suggests that antibodies could be used to prevent protein clusters from forming, which is believed to kill nerve cells.
Researchers have found a link between low HDL cholesterol and heart disease, suggesting that defective ABCA1 protein may play a role. Additionally, studies have shown that type 2 diabetes patients accumulate high levels of triglyceride-rich lipoprotein in the blood, which can contribute to heart disease.
Researchers uncovered new details about how proteins orchestrate cell division and how curcumin boosts the immune system to fight cancer. Additionally, scientists provided new insights into the toxic effects of tau protein aggregation in Alzheimer's disease.
Researchers found that diets high in fish, seafood, and grains reduce the risk of heart disease. Cholesterol buildup in lysosomes may contribute to heart disease, and restoring acidity could help clear arteries. A new link between Down Syndrome and Alzheimer's Disease was also discovered through cholesterol metabolism.
The Journal of Biological Chemistry published several studies revealing new insights into cholesterol metabolism without oxygen, a compound effective against blood cancer, bacteria's quorum sensing mechanism, and HIV infection. These discoveries could lead to the development of new pharmaceuticals and treatments for related diseases.
Researchers identified a new protein involved in egg activation and its role in fertilization. A chemical has been found effective against anthrax by blocking spore germination. A new protein also controls the growth of the hepatitis C virus, which could lead to new drug development.
Researchers have discovered that liver regeneration is driven by an increase in cell multiplication through regular cell divisions, rather than relying on embryonic-like processes. This finding could lead to more effective ways to stimulate liver growth and potentially improve treatment options for patients with liver diseases.
Researchers provide new insights into how a key protein used to fight viruses works, raising hopes for improved treatments against viral infection. Additionally, heart stem cells are shown to be unaffected by acute heart failure, making them available for cardiac recovery. A chemical called thioredoxin also helps prevent loss of neuron...
Dr. Andrew Z. Fire's article in November MCP explores the development of an assay to observe protein interactions in vivo, confirming previously documented interactions and discovering new ones in C. elegans. The study also identifies key associations between RNA interference and nonsense mediated decay pathways.
A genetic disorder causing hypoglycemia, congenital hyperinsulinism is linked to defects in insulin secretion by pancreatic cells. Mutations in the glutamate dehydrogenase gene impair enzyme sensitivity, leading to excessive insulin release and hypoglycemia.
Researchers have discovered a new compound that specifically targets FKBP38 receptor, reducing programmed cell death in neuronal cells. The compound protects neurons and promotes neural stem cell proliferation, offering potential therapeutic application for stroke and other neurodegenerative diseases.
Researchers have identified a stomach receptor for Helicobacter pylori, a common gut bacteria that causes peptic ulcers and gastric cancer. The discovery suggests that drugs targeting this receptor could prevent or treat these diseases.
Researchers found that compounds binding to CB2 receptor suppress white blood cell migration, a key step in fighting infections and inflammation. This discovery suggests potential therapeutic applications for cannabinoids in treating inflammatory diseases.
Researchers found that inhibiting heme oxygenase-1 activity reduces tumor growth in mice with Kaposi's sarcoma lesions. The study offers a potential new treatment for the disease.
Researchers analyzed the fatty acid composition of Blue Morpho butterflies and their larvae to discover that the transformation from larva to butterfly drastically reduces total fatty acid content. This significant loss in body fat may be essential for the health and survival of the butterfly during metamorphosis.
Researchers found that cystic fibrosis airway glands have defective gland secretion due to a lack of fluid secretion from glands. The study suggests that loss of CFTR-mediated fluid secretion is the main cause of mucus buildup in cystic fibrosis.
Researchers found that resveratrol, a compound in red wine, significantly reduces amyloid-beta peptide levels in cells. The compound is believed to stimulate the degradation of these peptides by the proteasome, a multi-protein complex. However, it remains unclear whether eating grapes can effectively prevent Alzheimer's disease.
Researchers discovered Klotho protein increases cell resistance to oxidative stress by detoxifying harmful reactive oxygen species. This finding may lead to the development of anti-aging drugs, potentially useful as medicines.
Researchers found that baby's genes have a significant impact on mother's lipoprotein levels, which can increase risk of cardiovascular disease. The study suggests that pregnancies may be less affected by maternal genetic defects if the fetus compensates for them.
Researchers have identified 16 new serine protease inhibitors in the saliva of medical leeches, which could be used to treat cardiovascular disease. The compounds may inhibit thrombus development and are a promising lead for anticoagulant and fibrinolytic drugs.
Researchers developed a hyper-responsive Stat1 molecule to amplify the body's immune response without side effects. This improvement could lead to treatments for viral infections, cancer, and other conditions with lower doses of interferon.
A diet high in soy protein prevents the accumulation of triglycerides and cholesterol in the liver despite obesity and hyperinsulinemia. This is achieved through reduced expression of genes involved in lipid production and increased breakdown of fatty acids.
Research reveals that sticky mutant proteins in patients with inherited ALS cause the disease by promoting abnormal interactions with other proteins or membranes. The study suggests that understanding how tissues handle these protein forms could lead to new treatments for some forms of ALS.
Tumors secrete fatty acids that block cytotoxic T lymphocytes' ability to kill cancer cells, reducing the efficacy of anti-cancer therapies. This discovery raises possibilities for new therapeutic targets and monitoring tumor aggressiveness through free fatty acid levels.
Researchers have identified 141 distinct proteins in the healthy human cornea, including classical blood proteins and anti-angiogenic factors. This comprehensive protein study may lead to future therapeutics for various corneal disorders, improving clinical classifications and potentially generating artificial corneas for transplantation.
Researchers discovered a new protein, CBP21, that speeds up chitin degradation by breaking down its structure. This discovery has potential applications in combating fungi and producing biofuels.
Researchers discovered that omega-3 fatty acids are not linked to depression as previously thought, but rather increased arachidonic acid levels in the brain may be responsible. Omega-6 fatty acid intake could also play a role in controlling depression.
A new polysaccharide, hyaluronan oligomers, has been discovered to sensitize drug-resistant breast cancer cells to several chemotherapeutic drugs by binding to CD44 receptor. Increasing hyaluronan synthesis in cells also increases resistance to drug treatment.
The Lipid Metabolites and Pathways Strategy (LIPID MAPS) consortium has proposed a new comprehensive classification system for lipids, dividing them into eight primary categories with further subdivisions. The system includes a nomenclature system and a unique identifier for each lipid molecule.
Researchers found that small soluble protein clusters called oligomers cause neurotoxicity by increasing membrane permeability. This challenges the long-held idea that insoluble fibrils are responsible for disease symptoms.
Researchers discovered that overexpressing insulin transcription factors MafA, PDX-1, and NeuroD in the liver of diabetic mice increased insulin gene expression and improved glucose tolerance. This breakthrough suggests a crucial role for MafA as a novel therapeutic target for diabetes.
Researchers have identified a missing enzyme in M. tuberculosis that plays a crucial role in the bacterium's ability to acquire iron through mycobactin synthesis. This discovery highlights the importance of understanding the iron scavenging pathway in TB and provides new avenues for developing effective anti-TB drugs.
Listeria uses host cell lipids to move within cells and spread through the body. The bacteria hijack the host cell's actin cytoskeleton using two membrane lipids, PIP2 and PIP3, which are essential for their movement.
Researchers solved the three-dimensional crystal structure of CD14, providing insights into its binding to LPS. The receptor has a large hydrophobic pocket that accommodates various ligands, including LPS and other microbial products.
Inducible nitric oxide synthase (iNOS) produces nitric oxide, contributing to inflammation and host defense. eNOS-derived NO accelerates host-defense responses but also leads to excessive inflammation and sepsis.
Dr. Goldstein and Dr. Brown will discuss their research on the regulated intramembrane proteolysis (RIP) of sterol regulatory element binding proteins (SREBPs), which regulates lipid biosynthesis and plasma cholesterol levels. Their work has been recognized with numerous awards, including Nobel Prize in Physiology or Medicine.
The William C. Rose Award lecture will focus on the importance of cytochrome P450s in drug development, endocrinology, and toxicology. Dr. Guengerich's recent work includes kinetic analysis and methods to define substrates and products of orphan P450s.
Dr. Strahl's research focuses on histone modifications, specifically the addition of ubiquitin to histone 2B by Rad6 enzyme. He also explores histone methylation and its regulation through various biochemical pathways.
Research reveals that SV40 large T antigen binds to tumor suppressor Fbw7, hijacking its function to promote tumorigenesis. This interaction highlights the importance of Fbw7 as a potential therapeutic target for cancer treatment strategies.